Literature DB >> 649520

Behavioral control of medicine compliance.

L H Epstein, B J Masek.   

Abstract

This study examined the effectiveness of several behavioral techniques on compliance of college students taking vitamin C on q.i.d. regimen. Compliance was assessed by a new technique using a variation of the urine tracer procedure designed specifically for this study. Subjects were provided vitamin C tablets, with three tablets per week containing phenazopyridine, a drug that produces a bright red-orange urine discoloration. Subjects were requested to indicate when urine discolorations occurred, and compliance was assessed by comparing the time of their report to the time predicted on the basis of the scheduled sequence of vitamin C and phenazopyridine tablets. Baseline compliance was assessed for 72 subjects over a three-week period, with the 40 most noncompliant subjects randomly assigned to four groups for Treatment I. The groups were: self-monitoring, taste, taste and self-monitoring, and a no-treatment control group. The self-monitoring procedure involved recording the time medicine was taken; the taste procedure involved providing the subjects with flavored tablets to increase the saliency of tablet taking; and the self-monitoring and taste procedure involved providing subjects with flavored tablets and asking them to record the flavor of each tablet they ingested. At the end of six weeks, half the subjects in each of these groups participated in response-cost procedures while the remaining subjects continued with their previous procedures. Response-cost procedures were implemented by returning a portion of the subjects' deposit only if a preset compliance criterion was met. Treatment II procedures were implemented for an additional three weeks. Results indicated the self-monitoring and taste plus self-monitoring procedures were superior during Treatment I. The implementation of response cost during Treatment II was associated with a marked improvement in compliance, independent of the history of noncompliance. The effects of the taste plus self-monitoring procedure were maintained during Treatment II and results obtained by this procedure were not significantly different from effects of response cost.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 649520      PMCID: PMC1311263          DOI: 10.1901/jaba.1978.11-1

Source DB:  PubMed          Journal:  J Appl Behav Anal        ISSN: 0021-8855


  18 in total

1.  Maintaining disulfiram ingestion among outpatient alcoholics: a security-deposit contingency contracting procedure.

Authors:  G Bigelow; D Strickler; I Liebson; R Griffiths
Journal:  Behav Res Ther       Date:  1976

2.  Patient compliance assessment in drug trials: usage and methods.

Authors:  B R Soutter; M C Kennedy
Journal:  Aust N Z J Med       Date:  1974-08

3.  Diagnosis and management of patient noncompliance.

Authors:  R F Gillum; A J Barsky
Journal:  JAMA       Date:  1974-06-17       Impact factor: 56.272

4.  Assessment of dosage deviation in outpatient drug research.

Authors:  K Rickels; E Briscoe
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 May-Jun

Review 5.  Compliance with medical regimens: a review of the literature.

Authors:  M V Marston
Journal:  Nurs Res       Date:  1970 Jul-Aug       Impact factor: 2.381

6.  Predicting mothers' compliance with pediatric medical regimens.

Authors:  M H Becker; R H Drachman; J P Kirscht
Journal:  J Pediatr       Date:  1972-10       Impact factor: 4.406

7.  A comparison of patient dosage deviation reports with pill counts.

Authors:  L C Park; R S Lipman
Journal:  Psychopharmacologia       Date:  1964-10-14

8.  Measuring intake of a prescribed medication. A bottle count and a tracer technique compared.

Authors:  H P Roth; H S Caron; B P Hsi
Journal:  Clin Pharmacol Ther       Date:  1970 Mar-Apr       Impact factor: 6.875

9.  Randomised clinical trial of strategies for improving medication compliance in primary hypertension.

Authors:  D L Sackett; R B Haynes; E S Gibson; B C Hackett; D W Taylor; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

10.  Why do schizophrenic patients refuse to take their drugs?

Authors:  T Van Putten
Journal:  Arch Gen Psychiatry       Date:  1974-07
View more
  9 in total

1.  Effects of text messaged self-monitoring on class attendance and punctuality of at-risk college student athletes.

Authors:  David F Bicard; Valorie Lott; Jessica Mills; Sara Bicard; Laura Baylot-Casey
Journal:  J Appl Behav Anal       Date:  2012

2.  Measurement of patient compliance and the interpretation of randomized clinical trials.

Authors:  R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  How useful is riboflavin as a tracer of medication compliance?

Authors:  I E Babiker; P R Cooke; M G Gillett
Journal:  J Behav Med       Date:  1989-02

4.  Assessing breast self-examination compliance in the natural environment.

Authors:  J A Mayer
Journal:  J Behav Med       Date:  1986-08

5.  Compliance and the doctor-patient relationship.

Authors:  C L Peck; N J King
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

6.  A method to increase compliance to exercise regimens in rheumatoid arthritis patients.

Authors:  C D Waggoner; R B LeLieuvre
Journal:  J Behav Med       Date:  1981-06

7.  Riboflavin as a tracer of medication compliance.

Authors:  P M Dubbert; A King; S R Rapp; D Brief; J E Martin; M Lake
Journal:  J Behav Med       Date:  1985-09

8.  Pills or skills for hyperactive children.

Authors:  K D O'Leary
Journal:  J Appl Behav Anal       Date:  1980

9.  Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement.

Authors:  Abigail J Herron; John J Mariani; Martina Pavlicova; Christina M Parrinello; Krysten W Bold; Frances R Levin; Edward V Nunes; Maria A Sullivan; Wilfred N Raby; Adam Bisaga
Journal:  Drug Alcohol Depend       Date:  2012-08-22       Impact factor: 4.492

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.